120 related articles for article (PubMed ID: 12373537)
1. The role of striatal metabotropic glutamate receptors in Parkinson's disease.
Ossowska K; Konieczny J; Wardas J; Gołembiowska K; Wolfarth S; Pilc A
Amino Acids; 2002; 23(1-3):193-8. PubMed ID: 12373537
[TBL] [Abstract][Full Text] [Related]
2. An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
Ossowska K; Konieczny J; Wardas J; Pietraszek M; Kuter K; Wolfarth S; Pilc A
Amino Acids; 2007 Feb; 32(2):179-88. PubMed ID: 16699817
[TBL] [Abstract][Full Text] [Related]
3. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
4. The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: review article.
Gołembiowska K; Konieczny J; Ossowska K; Wolfarth S
Amino Acids; 2002; 23(1-3):199-205. PubMed ID: 12373538
[TBL] [Abstract][Full Text] [Related]
5. The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.
Wardas J; Pietraszek M; Wolfarth S; Ossowska K
Neuroscience; 2003; 122(3):747-56. PubMed ID: 14622918
[TBL] [Abstract][Full Text] [Related]
6. The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats.
Ossowska K; Wardas J; Pietraszek M; Konieczny J; Wolfarth S
Neurosci Lett; 2003 May; 342(1-2):21-4. PubMed ID: 12727308
[TBL] [Abstract][Full Text] [Related]
7. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
[TBL] [Abstract][Full Text] [Related]
8. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.
Bonsi P; Cuomo D; Picconi B; Sciamanna G; Tscherter A; Tolu M; Bernardi G; Calabresi P; Pisani A
Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415
[TBL] [Abstract][Full Text] [Related]
9. The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors.
Ossowska K; Konieczny J; Pilc A; Wolfarth S
Brain Res; 2002 Sep; 950(1-2):88-94. PubMed ID: 12231232
[TBL] [Abstract][Full Text] [Related]
10. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity.
Orlando LR; Alsdorf SA; Penney JB; Young AB
Exp Neurol; 2001 Jan; 167(1):196-204. PubMed ID: 11161608
[TBL] [Abstract][Full Text] [Related]
11. Preproenkephalin mRNA expression in rat dorsal striatum induced by selective activation of metabotropic glutamate receptor subtype-5.
Parelkar NK; Wang JQ
Synapse; 2003 Mar; 47(4):255-61. PubMed ID: 12539198
[TBL] [Abstract][Full Text] [Related]
12. Posttreatment with group II metabotropic glutamate receptor agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate is only weakly effective on seizures in immature rats.
Folbergrová J; Druga R; Tsenov G; Haugvicová R; Otáhal J
Brain Res; 2009 Jun; 1273():144-54. PubMed ID: 19341715
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injury.
Fei Z; Zhang X; Bai HM; Jiang XF; Wang XL
J Clin Neurosci; 2006 Dec; 13(10):1023-7. PubMed ID: 17113985
[TBL] [Abstract][Full Text] [Related]
14. Role of metabotropic glutamate receptors in animal models of Parkinson's disease.
Senkowska A; Ossowska K
Pol J Pharmacol; 2003; 55(6):935-50. PubMed ID: 14730087
[TBL] [Abstract][Full Text] [Related]
15. Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons.
Bonsi P; Cuomo D; De Persis C; Centonze D; Bernardi G; Calabresi P; Pisani A
Neuropharmacology; 2005; 49 Suppl 1():104-13. PubMed ID: 16005029
[TBL] [Abstract][Full Text] [Related]
16. Role of peripheral group I and II metabotropic glutamate receptors in IL-1beta-induced mechanical allodynia in the orofacial area of conscious rats.
Ahn DK; Kim KH; Jung CY; Choi HS; Lim EJ; Youn DH; Bae YC
Pain; 2005 Nov; 118(1-2):53-60. PubMed ID: 16154694
[TBL] [Abstract][Full Text] [Related]
17. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
Oueslati A; Breysse N; Amalric M; Kerkerian-Le Goff L; Salin P
Eur J Neurosci; 2005 Dec; 22(11):2765-74. PubMed ID: 16324110
[TBL] [Abstract][Full Text] [Related]
18. Functional and ultrastructural analysis of group I mGluR in striatal fast-spiking interneurons.
Bonsi P; Sciamanna G; Mitrano DA; Cuomo D; Bernardi G; Platania P; Smith Y; Pisani A
Eur J Neurosci; 2007 Mar; 25(5):1319-31. PubMed ID: 17425558
[TBL] [Abstract][Full Text] [Related]
19. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.
Sibille P; Lopez S; Brabet I; Valenti O; Oueslati N; Gaven F; Goudet C; Bertrand HO; Neyton J; Marino MJ; Amalric M; Pin JP; Acher FC
J Med Chem; 2007 Jul; 50(15):3585-95. PubMed ID: 17602546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
